CN117721074A - Serum-free adipogenic induction differentiation medium for poultry, induction method and application - Google Patents
Serum-free adipogenic induction differentiation medium for poultry, induction method and application Download PDFInfo
- Publication number
- CN117721074A CN117721074A CN202410034653.5A CN202410034653A CN117721074A CN 117721074 A CN117721074 A CN 117721074A CN 202410034653 A CN202410034653 A CN 202410034653A CN 117721074 A CN117721074 A CN 117721074A
- Authority
- CN
- China
- Prior art keywords
- differentiation
- serum
- medium
- poultry
- free
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000004069 differentiation Effects 0.000 title claims abstract description 82
- 230000006698 induction Effects 0.000 title claims abstract description 35
- 244000144977 poultry Species 0.000 title claims abstract description 30
- 230000002293 adipogenic effect Effects 0.000 title claims abstract description 28
- 238000000034 method Methods 0.000 title claims abstract description 25
- 238000004113 cell culture Methods 0.000 claims abstract description 22
- 230000024245 cell differentiation Effects 0.000 claims abstract description 19
- 235000013372 meat Nutrition 0.000 claims abstract description 19
- 230000008569 process Effects 0.000 claims abstract description 11
- 239000002609 medium Substances 0.000 claims description 38
- 235000019197 fats Nutrition 0.000 claims description 37
- 239000001963 growth medium Substances 0.000 claims description 30
- 239000002243 precursor Substances 0.000 claims description 27
- 239000000654 additive Substances 0.000 claims description 20
- 230000000996 additive effect Effects 0.000 claims description 18
- 235000020776 essential amino acid Nutrition 0.000 claims description 14
- 239000003797 essential amino acid Substances 0.000 claims description 14
- 238000000338 in vitro Methods 0.000 claims description 12
- 241000271566 Aves Species 0.000 claims description 10
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 10
- 230000035755 proliferation Effects 0.000 claims description 7
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 6
- 102000004877 Insulin Human genes 0.000 claims description 5
- 108090001061 Insulin Proteins 0.000 claims description 5
- 229940125396 insulin Drugs 0.000 claims description 5
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 4
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 4
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 4
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 claims description 4
- 102000004338 Transferrin Human genes 0.000 claims description 4
- 108090000901 Transferrin Proteins 0.000 claims description 4
- 230000001939 inductive effect Effects 0.000 claims description 4
- 238000012360 testing method Methods 0.000 claims description 4
- 239000012581 transferrin Substances 0.000 claims description 4
- 239000007640 basal medium Substances 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 claims description 2
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 2
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 2
- 229930064664 L-arginine Natural products 0.000 claims description 2
- 235000014852 L-arginine Nutrition 0.000 claims description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims description 2
- 239000004158 L-cystine Substances 0.000 claims description 2
- 235000019393 L-cystine Nutrition 0.000 claims description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- 229930182844 L-isoleucine Natural products 0.000 claims description 2
- 239000004395 L-leucine Substances 0.000 claims description 2
- 235000019454 L-leucine Nutrition 0.000 claims description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 2
- 229930195722 L-methionine Natural products 0.000 claims description 2
- 229930182821 L-proline Natural products 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- 229960003767 alanine Drugs 0.000 claims description 2
- 229960001230 asparagine Drugs 0.000 claims description 2
- 229960005261 aspartic acid Drugs 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 229960003067 cystine Drugs 0.000 claims description 2
- 229960002989 glutamic acid Drugs 0.000 claims description 2
- 229960002449 glycine Drugs 0.000 claims description 2
- 229960002885 histidine Drugs 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- 229960003136 leucine Drugs 0.000 claims description 2
- 230000007246 mechanism Effects 0.000 claims description 2
- 229960004452 methionine Drugs 0.000 claims description 2
- 229960002429 proline Drugs 0.000 claims description 2
- 229960001153 serine Drugs 0.000 claims description 2
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 claims description 2
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 claims description 2
- 229960002898 threonine Drugs 0.000 claims description 2
- 229960004441 tyrosine Drugs 0.000 claims description 2
- 229960004295 valine Drugs 0.000 claims description 2
- 210000002966 serum Anatomy 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 7
- 239000000126 substance Substances 0.000 abstract description 6
- 210000004102 animal cell Anatomy 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 40
- 235000013594 poultry meat Nutrition 0.000 description 21
- 210000001789 adipocyte Anatomy 0.000 description 14
- 241000287828 Gallus gallus Species 0.000 description 10
- 241000272525 Anas platyrhynchos Species 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 229940024606 amino acid Drugs 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 230000011759 adipose tissue development Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 230000009815 adipogenic differentiation Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 210000000577 adipose tissue Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- YRQNKMKHABXEJZ-UVQQGXFZSA-N chembl176323 Chemical compound C1C[C@]2(C)[C@@]3(C)CC(N=C4C[C@]5(C)CCC6[C@]7(C)CC[C@@H]([C@]7(CC[C@]6(C)[C@@]5(C)CC4=N4)C)CCCCCCCC)=C4C[C@]3(C)CCC2[C@]2(C)CC[C@H](CCCCCCCC)[C@]21C YRQNKMKHABXEJZ-UVQQGXFZSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 239000012192 staining solution Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 210000004003 subcutaneous fat Anatomy 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000272522 Anas Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000022983 regulation of cell cycle Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a serum-free adipogenic induction differentiation medium for poultry, an induction method and application thereof, and relates to the technical field of animal cell differentiation. The serum-free adipogenic induction differentiation medium for poultry provided by the invention does not contain any serum component, has definite chemical components and good differentiation effect, and is convenient for promoting the industrialization process of cell culture meat.
Description
Technical Field
The invention relates to the technical field of animal cell differentiation, in particular to a serum-free adipogenesis induced differentiation culture medium for poultry, an induction method and application.
Background
The cell culture meat is a product obtained by extracting animal stem cells, performing proliferation and directional differentiation in vitro, and collecting and processing. Fat is one of the main components of meat and plays a key role in the texture, mouthfeel and oral sensation of cell-cultured meat. First, adipocytes can provide the fullness and mouthfeel of meat. Fat droplets in adipocytes can give the meat a juicy character, making it more palatable. In addition, the fat cells can influence the viscosity and the oral feeling of the meat, so that the meat is more similar to the taste of the traditional meat. In addition, adipocytes are also critical to the nutritional properties of cell-cultured meats.
Fat has an important impact on the health and physiological functions of birds. First, fat plays a role in energy storage and energy supply in birds. The fat also provides protection and insulation to the birds, which can help the birds maintain a stable body temperature in a cold environment. In poultry food production, fat is also very important for the quality and mouthfeel of the product. The proper amount of fat can endow the poultry meat with rich mouthfeel and flavor, and make the poultry meat more juicy and delicious.
Adipocyte differentiation refers to the process by which undifferentiated adipose precursor cells are transformed into mature adipocytes. This process is critical to the proper development and function of adipose tissue. First, adipocyte differentiation is a critical step in adipose tissue formation and growth. During adipocyte differentiation, adipose precursor cells undergo multiple stages of cell proliferation, cell cycle regulation, and cell differentiation, and eventually differentiate into mature adipocytes. These mature adipocytes can synthesize and store fat, form adipose tissue, and have an impact on energy metabolism and endocrine function.
Serum, which is often used as one of the components of cell proliferation and differentiation media in cell culture, contains various growth factors, nutrients and extracellular matrix components, which can provide the support required for cell growth and differentiation. However, serum also presents some potential risks and limitations in cell culture. First, there may be batch-to-batch differences in serum composition and quality. Different batches of serum may contain different components and concentrations, which may have an effect on cell growth and differentiation and lead to instability of the experimental results. Second, serum may contain pathogenic microorganisms, viruses and other contaminants. Although commercial serum products are processed and tested to ensure that they meet relevant quality standards, there is a potential risk of infection. Furthermore, serum may introduce unnecessary variables or limitations. For example, lipid and protein components in serum may interfere with cell signaling, metabolism, and synthesis of extracellular matrix. In adipocyte culture, the use of serum may interfere with the differentiation and functional expression of adipocytes. Serum is expensive, and the preparation of serum requires slaughtering animals, so that the cost for cultivating meat by cells is high, and animal source substances should be avoided as much as possible.
Fat of poultry is mainly synthesized in liver, and the head synthesis capacity of in vitro fat cells is poor, so that the cocktail method (insulin, dexamethasone, IBMX) used by traditional mammals has poor induction effect and almost no fat drop is generated. The in vitro differentiation of avian adipocytes requires the addition of exogenous fatty acids. The formula of the culture medium for inducing the differentiation of the fat precursor cells of the poultry, which is commonly used at present, is that 10 percent of fetal bovine serum and oleic acid are added into a basic culture medium. However, the chemical components of the culture medium are not clear due to the addition of the fetal calf serum, and the culture medium has the problems of unstable components of different batches of culture medium, easy pathogen pollution such as viruses, high cost and the like. In addition, the differentiation effect is poor and unstable. This makes it impossible to produce cell culture meat efficiently, stably and inexpensively on a large scale using the medium, and hinders the progress of industrialization of cell culture meat.
Therefore, there is an urgent need to develop a serum-free adipogenic induction differentiation medium with definite chemical composition, low cost and high efficiency, and solve the problem that the industrialization process of cell culture meat is hindered due to low differentiation efficiency and poor repeatability at present.
Disclosure of Invention
Aiming at the problems in the prior art, the invention provides a serum-free adipogenesis induction differentiation medium for poultry and an induction method thereof, which are used for solving the problem that the existing cell adipogenesis differentiation technology hinders the industrialization process of cell culture meat due to low efficiency and poor repeatability.
The technical scheme adopted by the invention is as follows:
a serum-free adipogenic induction differentiation culture medium for poultry consists of a basal culture medium and a cell culture auxiliary factor, wherein the cell culture auxiliary factor consists of 5-10 mu g/mL of insulin, 100-200 mu mol/L of sodium oleate, 10-50 mu mol/L of linoleic acid, 5-10 mu g/mL of transferrin, 0.5% -1% by volume of essential amino acid additive, 0.05-0.1 mmol/L of non-essential amino acid additive and 1-2 mmol/L of GlutaMAX ™ additive.
The invention aims to provide an improved cell adipogenic induction differentiation medium with definite chemical composition for adipogenic induction differentiation of fat precursor cells in vitro, which does not contain serum components. The serum-free means that any animal serum components including fetal bovine serum, calf serum, chicken serum, duck serum, horse serum and the like are not added, the modified cell adipogenic induction differentiation culture medium is a fat precursor cell differentiation culture medium added with cell culture auxiliary factors, and the serum components in the traditional fat precursor cell adipogenic induction differentiation culture medium are replaced by adding the cell culture auxiliary factors; the basal medium also does not contain penicillin streptomycin diabody solution.
Preferably, the basal medium is one of DMEM and DMEM/F12 medium.
Preferably, the essential amino acid additive comprises L-arginine, L-cystine, L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-phenylalanine, L-threonine, L-tryptophan, L-tyrosine, L-valine.
Preferably, the non-essential amino acid additives include L-alanine, L-glutamic acid, L-asparagine, L-aspartic acid, L-proline, L-serine and glycine.
The induction method for inducing the cell adipogenic differentiation by adopting the serum-free adipogenic induced differentiation medium for poultry, which comprises the following steps:
(1) Taking fat precursor cells of poultry, culturing in vitro, growing to a confluence of more than 80%, discarding proliferation culture medium, adding serum-free adipogenic induction differentiation culture medium of the poultry, and recording the current day of the addition of the differentiation culture medium as 0 d;
(2) And (3) inducing differentiation for 2-6 d to realize fat-forming induced differentiation of the poultry, wherein in the induced differentiation process, a differentiation culture medium is changed every 1-2 d.
The serum-free adipogenesis induced differentiation medium for poultry is applied to the preparation of the differentiation medium for seed cells in the process of cultivating meat by poultry organisms.
The serum-free adipogenic induction differentiation medium for poultry is applied as a test reagent in the process of testing the differentiation performance of the poultry seed cells by using a cell differentiation method.
In summary, compared with the prior art, the invention has the following advantages and beneficial effects:
1. the serum-free adipogenic induction differentiation culture medium for poultry provided by the invention does not contain any serum component, has definite chemical components, and is convenient for promoting the industrialization process of cell culture meat;
2. the serum-free adipogenic induced differentiation medium for poultry provided by the invention has good adipogenic differentiation effect, and experimental researches show that after the modified adipogenic induced differentiation medium for cells of the invention is adopted to conduct in vitro induced differentiation on fat precursor cells of 6 d, lipid drops appear on almost all cells, and the cell differentiation efficiency reaches 100%;
3. the invention provides a universal serum-free adipogenesis induced differentiation culture medium for poultry and an induction method, which have important significance for researching the mechanism of poultry fat development and preparing cell culture meat.
Drawings
FIG. 1 is a microscopic view of chicken fat precursor cells;
FIG. 2 is a microscopic view of chicken fat precursor cells after serum-free adipogenic induced differentiation 6 d;
FIG. 3 shows the results of repeated experiments of chicken fat precursor cells after serum-free adipogenic induced differentiation of 6 d;
FIG. 4 is a microscopic view of duck fat precursor cells;
fig. 5 is a microscopic view of duck fat precursor cells after serum-free adipogenic induced differentiation 6 d;
fig. 6 shows the results of repeated experiments of duck fat precursor cells after serum-free adipogenic induced differentiation of 6 d.
Detailed Description
The advantages and various effects of the present invention will be more clearly apparent from the following detailed description and examples. It will be understood by those skilled in the art that these specific embodiments and examples are intended to illustrate the invention, not to limit the invention.
Throughout the specification, unless specifically indicated otherwise, the terms used herein should be understood as meaning as commonly used in the art. Accordingly, unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In case of conflict, the present specification will control.
Unless otherwise specifically indicated, the various raw materials, reagents, instruments, equipment and the like used in the present invention are commercially available or may be prepared by existing methods.
The present application will be described in detail with reference to examples and experimental data.
Example 1 this example explores the differentiation of chicken fat precursor cells, and is performed as follows:
(1) Extracting chicken fat precursor cells: cutting subcutaneous fat tissue of chicken into pieces 1 mm 3 Adding collagenase I working solution, digesting at 37 ℃ for 40 min, adding a proper amount of complete culture medium to stop digestion, filtering and centrifuging to obtain fat precursor cells, adding complete culture medium to resuspend cell sediment, counting, spreading to a cell culture dish for proliferation culture, wherein the microscopic morphology of the obtained chicken fat precursor cells is shown in figure 1;
(2) Removing proliferation medium, adding amplified chicken fat precursor cells into fowl serum-free lipid formation induction differentiation medium, adding differentiation medium, and making the culture medium 0 d, wherein the differentiation medium comprises basic medium and cell culture cofactorThe basic culture medium is DMEM culture medium, the cell culture auxiliary factor consists of 6 mu g/mL insulin, 150 mu mol/L sodium oleate, 40 mu mol/L linoleic acid, 8 mu g/mL transferrin, 0.6% of essential amino acid additive by volume, 0.08 mmol/L nonessential amino acid additive and 1.5 mmol/L GlutaMAX ™ additive, and the essential amino acid additive is Gibcom TM MEM amino acid solution (50X), cat# 11130051; the non-essential amino acid additive is Gibcom TM MEM optional amino acid solution (100X), cat No. 11140050;
(3) Induced differentiation 6 d realizes the induced differentiation of chicken fat, and in the induced differentiation process, the differentiation medium is changed every 1-2 d.
The differentiation effect is checked by the following steps:
(1) Removing the adipogenic induction differentiation medium, and gently rinsing with PBS for 3 times;
(2) Cell fixation was performed for 20 min with 4% PFA;
(3) Adding 0.1% PBSTr (0.1% triton X-100 in PBS) for cell permeation for 15 min, and changing permeation solution every 5 min;
(4) Removing the penetrating fluid and rinsing for 1 time by PBS;
(5) Adding 5 mu mol/L BODIPY dye liquor and 1.5 mu g/mL DAPI dye liquor, and dyeing for 12 min in a dark place;
(6) Discarding the staining solution, and rinsing with PBS for 3 times;
(7) Anti-fluorescence quenchers were added, observed using a fluorescence microscope and photographed.
As shown in FIG. 2, it can be seen that after the specific modified cell adipogenic differentiation medium is used for in vitro induced differentiation of fat precursor cells for 6 d, the cell differentiation efficiency reaches 100%, and as shown in FIG. 3, we repeat the above experimental process for 2 times, after in vitro induced differentiation for 6 d, the cell differentiation efficiency reaches 100% and 100%, respectively, which indicates that the method has good repeatability and high cell differentiation rate.
Example 2 this example explores the differentiation of duck fat precursor cells, and is performed as follows:
(1) Extracting duck fat precursor cells: taking subcutaneous adipose tissue of duck and shearingCrushing into 1 mm 3 Adding collagenase I working solution, digesting for 40 min at 37 ℃, adding 9 times of complete culture medium to stop digestion, filtering, spreading on a cell culture dish for proliferation culture, and obtaining microscopic morphology of duck fat precursor cells shown in figure 4;
(2) Removing proliferation medium, adding the amplified duck fat precursor cells into fowl serum-free lipid formation induction differentiation medium, adding differentiation medium, and making the beta-day mark 0 d, wherein the differentiation medium consists of basic medium and cell culture auxiliary factor, the basic medium is DMEM medium, the cell culture auxiliary factor consists of 6 μg/mL insulin, 150 μmol/L sodium oleate, 40 μmol/L linoleic acid, 8 μg/mL transferrin, 0.6% by volume of essential amino acid additive, 0.08 mmol/L nonessential amino acid additive, 1.5 mmol/L GlutaMAX ™ additive, and the essential amino acid additive is Gibcom TM MEM amino acid solution (50X), cat# 11130051; the non-essential amino acid additive is Gibcom TM MEM optional amino acid solution (100X), cat No. 11140050;
(3) And the induced differentiation is 6 d, so that the fat-forming induced differentiation of the ducks is realized, and the differentiation culture medium is replaced every 1-2 d in the induced differentiation process.
The differentiation effect is checked by the following steps:
(1) Removing the differentiation medium, and gently rinsing with PBS for 3 times;
(2) Cell fixation was performed for 20 min with 4% PFA;
(3) Adding 0.1% PBSTr for cell permeation for 15 min, and changing permeation solution every 5 min;
(4) Removing the penetrating fluid and rinsing for 1 time by PBS;
(5) Adding 5 mu mol/L BODIPY dye liquor and 1.5 mu g/mLDAPI dye liquor, and dyeing for 12 min in dark place;
(6) Discarding the staining solution, and rinsing with PBS for 3 times;
(7) Anti-fluorescence quenchers were added, observed using a fluorescence microscope and photographed.
As shown in FIG. 5, it is known that the cell differentiation efficiency reaches 100% after the in vitro induced differentiation of the fat precursor cells by using the specific modified cell adipogenic differentiation medium is 6 d, and as shown in FIG. 6, we repeat the above experimental process 2 times, and after the in vitro induced differentiation is 6 d, the cell differentiation efficiency reaches 100% and 100%, respectively, which indicates that the method has good repeatability and high cell differentiation rate.
The foregoing examples merely represent specific embodiments of the present application, which are described in more detail and are not to be construed as limiting the scope of the present application. It should be noted that, for those skilled in the art, several variations and modifications can be made without departing from the technical solution of the present application, which fall within the protection scope of the present application.
Claims (8)
1. A serum-free adipogenic induction differentiation culture medium for poultry is characterized by comprising a basal culture medium and a cell culture auxiliary factor, wherein the cell culture auxiliary factor comprises 5-10 mu g/mL of insulin, 100-200 mu mol/L of sodium oleate, 10-50 mu mol/L of linoleic acid, 5-10 mu g/mL of transferrin, 0.5% -1% by volume of essential amino acid additive, 0.05-0.1 mmol/L of non-essential amino acid additive and 1-2 mmol/L of GlutaMAX ™ additive.
2. The avian serum-free lipid-forming induction differentiation medium according to claim 1 wherein the basal medium is one of DMEM, DMEM/F12 medium.
3. The avian serum-free lipid-forming induction differentiation medium according to claim 1 wherein the essential amino acid additive comprises L-arginine, L-cystine, L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-phenylalanine, L-threonine, L-tryptophan, L-tyrosine, L-valine.
4. The avian serum-free lipid-forming induction differentiation medium according to claim 1 wherein the non-essential amino acid additives comprise L-alanine, L-glutamic acid, L-asparagine, L-aspartic acid, L-proline, L-serine and glycine.
5. The induction method for cell differentiation by using the serum-free adipogenic induction differentiation medium for poultry according to any one of claims 1 to 4, which is characterized by comprising the following steps:
(1) Taking fat precursor cells of poultry, culturing in vitro, growing to a confluence of more than 80%, discarding proliferation culture medium, adding serum-free adipogenic induction differentiation culture medium of the poultry, and recording the current day of the addition of the differentiation culture medium as 0 d;
(2) And (3) inducing differentiation for 2-6 d to realize adipogenic induced differentiation of the avian fat precursor cells, wherein in the induced differentiation process, a differentiation culture medium is changed every 1-2 d.
6. The use of the serum-free lipid-forming induction differentiation medium for poultry according to any one of claims 1 to 4 as a differentiation medium for seed cells in the preparation of poultry biological cultivation meat.
7. The use of the serum-free adipogenic induction differentiation medium for poultry according to any one of claims 1 to 4 as a test reagent in the process of testing the cell differentiation performance of avian seeds by using a cell differentiation method.
8. The use of the serum-free adipogenic induction differentiation medium for poultry according to any one of claims 1 to 4 for studying adipogenic mechanism by using in vitro cell differentiation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410034653.5A CN117721074B (en) | 2024-01-10 | 2024-01-10 | Serum-free adipogenic induction differentiation medium for poultry, induction method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410034653.5A CN117721074B (en) | 2024-01-10 | 2024-01-10 | Serum-free adipogenic induction differentiation medium for poultry, induction method and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN117721074A true CN117721074A (en) | 2024-03-19 |
| CN117721074B CN117721074B (en) | 2024-04-30 |
Family
ID=90201756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410034653.5A Active CN117721074B (en) | 2024-01-10 | 2024-01-10 | Serum-free adipogenic induction differentiation medium for poultry, induction method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117721074B (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000157260A (en) * | 1998-11-26 | 2000-06-13 | Toyobo Co Ltd | Differentiation induction of primary precursor adipose cell, and culture medium for its differentiation |
| CN115927172A (en) * | 2022-12-15 | 2023-04-07 | 南京周子未来食品科技有限公司 | Improved culture medium with specific chemical components for inducing in vitro adipogenic differentiation and application thereof |
-
2024
- 2024-01-10 CN CN202410034653.5A patent/CN117721074B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000157260A (en) * | 1998-11-26 | 2000-06-13 | Toyobo Co Ltd | Differentiation induction of primary precursor adipose cell, and culture medium for its differentiation |
| CN115927172A (en) * | 2022-12-15 | 2023-04-07 | 南京周子未来食品科技有限公司 | Improved culture medium with specific chemical components for inducing in vitro adipogenic differentiation and application thereof |
Non-Patent Citations (5)
| Title |
|---|
| ALEMU REGASSA, 等: "Effect of oleic acid and chicken serum on the expression of adipogenic transcription factors and adipogenic differentiation in hen preadipocytes", CELL BIOLOGY INTERNATIONAL, 31 December 2013 (2013-12-31) * |
| S. C. BUTTERWITH: "Regulators of Adipocyte Precursor Cells", POULTRY SCIENCE, 31 December 1997 (1997-12-31) * |
| SYLVIANE DESLEX, 等: "Development of a Chemically Defined Serum-free Medium for Differentiation of Rat Adipose Precursor Cells", EXPERIMENTAL CELL RESEARCH, 31 December 1987 (1987-12-31) * |
| YVES REYNE, 等: "Differentiation of rabbit adipocyte precursor cells in a serum-free medium", IN VITRO CELLULAR AND DEVELOPMENTAL BIOLOGY, 31 December 1989 (1989-12-31) * |
| 朱惠娟;邓洁英;龚凤英;史轶蘩;: "无血清原代培养人前脂肪细胞并诱导分化", 基础医学与临床, no. 07, 20 July 2006 (2006-07-20) * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN117721074B (en) | 2024-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103857789B (en) | Prepare mescenchymal stem cell basal medium and utilize the method that mescenchymal stem cell basal medium prepares cell therapy product and the differentiation product obtained by this culture medium | |
| JP2024073421A (en) | Ex vivo meat production | |
| JP2023093403A (en) | Cell culturing method using animal muscle tissue extract | |
| US20220298480A1 (en) | Methods for improving cell growth with species-specific or genus-specific proteins and the applications thereof | |
| WO2024125632A1 (en) | Culture medium for inducing in-vitro adipogenic differentiation of cells and use thereof | |
| CN109370985A (en) | A kind of human umbilical cord mesenchymal stem cells large-scale culture serum free medium | |
| Yuen Jr et al. | Perspectives on scaling production of adipose tissue for food applications | |
| Lee et al. | Unlocking the potential of stem cells: Their crucial role in the production of cultivated meat | |
| Behera et al. | Review on cultured meat: ethical alternative to animal industrial farming | |
| CN117721074B (en) | Serum-free adipogenic induction differentiation medium for poultry, induction method and application | |
| CN114736851B (en) | Method for preparing vegetable-based fat-cultured meat | |
| CN113215083B (en) | Establishment method of turbot liver parenchymal cell line and cell line | |
| CN109957510B (en) | Method for synchronously culturing microalgae | |
| KR101010077B1 (en) | Method of external cultivation for cow's egg cell by using cultivation composition derived from undifferentiated human stem cell | |
| Dai et al. | Development of a serum‐free medium for myoblasts long‐term expansion and 3D culture for cell‐based meat | |
| US20240263138A1 (en) | Methods for preparing a food ingredient and compositions produced thereby | |
| CN107119010B (en) | Synthetic adhesion culture medium for cell culture and preparation method thereof | |
| CN115044541B (en) | Immortalized pig fat precursor cell line with high differentiation efficiency, and construction method and application thereof | |
| CN111996162B (en) | Chondrogenic differentiation medium and application thereof | |
| Huang et al. | An immortal porcine preadipose cell strain for efficient production of cell-cultured fat | |
| RU2710718C1 (en) | Method of modifying proliferative activity of cell cultures of mammals | |
| CN1863907A (en) | Method of preparing hair papilla cell preparation, composition and method for regenerating hair follicle and animal having regenerated hair follicle | |
| KR20240041364A (en) | Cultured Adipose Tissue | |
| CN116917463A (en) | Pluripotent stem cell aggregates for use in the culture of the meat industry and micro-tissues obtained therefrom | |
| CN117004553A (en) | Woody musk glandular cell culture medium and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |